Health Propaganda, Exposed
Before you act: Don't stop, replace, or delay any treatment without talking to your doctor.
“Intravenous infusion of up to 20 mg of BPC-157 in 2 healthy adults showed no adverse effects and was well-tolerated.”
Human pilot study, n=2, no control group, 3 days. Most BPC-157 evidence is animal/lab.
"The research received no funding of any kind." Authors declare no conflict of interest. Performed at a private clinic.
An IRB-approved pilot in which two people who had previously received IV BPC-157 were given 10 mg then 20 mg infusions, with blood work and vital signs.
"The infusions of BPC-157 resulted in no measurable effects on the tested biomarkers of the heart, liver, kidneys, thyroid, or blood glucose levels ... with no side effects reported."
Two people over three days cannot establish safety; the authors write "Future studies are also needed to confirm the safety" and that, being unfunded, the study "lacked a large sample size, a sham control group, and a longer timeframe." It tested no efficacy.
BPC-157 is not an approved drug in the U.S., Australia and elsewhere; independent reporting (see Guardian entry) describes it as having "little evidence in humans."